(Q33593437)

English

Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema (English)

1 reference

Europe PubMed Central

28 July 2017

1 reference

based on heuristic

inferred from title

retinal vein occlusion

1 reference

based on heuristic

inferred from title

Nicolas Feltgen

9

object named as

Nicolas Feltgen

1 reference

Europe PubMed Central

28 July 2017

author name string

Andreas Stahl

1

1 reference

Europe PubMed Central

28 July 2017

Armin Buchwald

2

1 reference

Europe PubMed Central

28 July 2017

Gottfried Martin

3

1 reference

Europe PubMed Central

28 July 2017

Bernd Junker

4

1 reference

Europe PubMed Central

28 July 2017

Jing Chen

5

1 reference

Europe PubMed Central

28 July 2017

Lutz L Hansen

6

1 reference

Europe PubMed Central

28 July 2017

Hansjurgen T Agostini

7

1 reference

Europe PubMed Central

28 July 2017

Lois E H Smith

8

1 reference

Europe PubMed Central

28 July 2017

publication date

1 October 2010

1 reference

Europe PubMed Central

28 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

28 July 2017

30

1 reference

Europe PubMed Central

28 July 2017

9

1 reference

Europe PubMed Central

28 July 2017

1524-1529

1 reference

Europe PubMed Central

28 July 2017

Review of anti-VEGF therapy in proliferative diabetic retinopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Erythropoietin deficiency decreases vascular stability in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Neuroprotection by erythropoietin administration after experimental traumatic brain injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Bevacizumab in retinal vein occlusion-results of a prospective case series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Erythropoietin protects from post-traumatic edema in the rat brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Regulation of erythropoietin production. New insights into molecular mechanisms of oxygen homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

21 June 2018

Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Intravitreal bevacizumab (avastin) in central retinal vein occlusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Elevated erythropoietin in vitreous with ischemic retinal diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016716

30 October 2018

Oxygen-induced retinopathy in the mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/IAE.0B013E3181D37539

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33593437&oldid=1987925261"